Better allograft survival in erythrocyte type-O recipients correlates with resistance to cytomegalovirus infections.
D000017:ABO Blood-Group System / Q000235:genetics*; D000328:Adult; D001803:Blood Transfusion; D003586:Cytomegalovirus Infections / Q000235:genetics / Q000276:immunology*; D005260:Female; D006085:Graft Survival; D006680:HLA Antigens / Q000235:genetics; D006650:Histocompatibility Testing; D006801:Humans; D007113:Immunity, Innate; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D010641:Phenotype
D000017:ABO Blood-Group System; D006680:HLA Antigens